Close Menu

NEW YORK – Natera said on Friday that it has filed a lawsuit against ArcherDx in the US District Court for the District of Delaware for allegedly infringing Natera's US Patent No. 10,731,220.

The patent is titled "Methods for Simultaneous Amplification of Target Loci" and was issued by the United States Patent and Trademark Office on Aug. 4, 2020. Natera said it is one of more than 200 patents issued or pending in its global intellectual property portfolio, including more than 60 in the field of oncology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.